Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy

12 Aug 2021

Abstract excerpt

PURPOSE OF REVIEW: Molecular forms of allergen-specific immunotherapy (AIT) are continuously emerging to improve the efficacy of the treatment, to shorten the duration of protocols and to prevent any side effects. The present review covers the recent progress in the development of AIT based on nucleic acid encoding allergens or CpG oligodeoxynucleotides (CpG-ODN). RECENT FINDINGS: Therapeutic vaccinations with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Food Allergy and Anaphylaxis Research
Share to Immunotherapy and Immune Responses
Share to Pediatric health and respiratory diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34387280
DOI: 10.1097/aci.0000000000000772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapyPMID 34387280Read ↗

Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic diseaseSemantic proximity Read ↗

Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1‐specific immunotherapy using high‐dose CpG adjuvantSemantic proximity Read ↗

Allergy Vaccines Using a Mycobacterium-Secreted Antigen, Ag85B, and an IL-4 Antagonist.Semantic proximity Read ↗

Towards immunotherapy for peanut allergy.Semantic proximity Read ↗

Leveraging mRNA platform for the development of vaccines against egg allergySemantic proximity Read ↗

Methylation changes induced by a glycodendropeptide immunotherapy and associated to tolerance in miceSemantic proximity Read ↗

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious DiseasesSemantic proximity Read ↗

Eat Dirt: CpG DNA and Immunomodulation of AsthmaSemantic proximity Read ↗

Toll-Like Receptor 9 Activation with CpG Oligodeoxynucleotides for Asthma Therapy*Semantic proximity Read ↗

Immunization with an adeno-associated viral vectored allergy vaccine containing Der p1-Der p2 effectively alleviates an asthmatic phenotype in miceSemantic proximity Read ↗

mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergensSemantic proximity Read ↗

Epigenetic/genetic variations in CG-rich elements of immune-related genes contribute to food allergy development during childhood.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.